Defining Drug Response for Stratified Medicine

The premise for stratified medicine is that drug efficacy, drug safety, or both, vary between groups of patients, and biomarkers can be used to facilitate more targeted prescribing, with the aim of improving the benefit:risk ratio of treatment. However, many factors can contribute to the variability in response to drug treatment. Inadequate characterisation of the nature and degree of variability can lead to the identificationof biomarkers that have limited utility in clinical settings.

Spotlight

Austriamed - Medical Treatments in Austria

AT-MED offers access to premium medical services in top clinics and hospitals in Austria. Through AT-MED you have full medical testings in half a day, in the same medical unit and a reliable team made up of world-renowned doctors and professors, for whom your needs will come first. In the Austrian medical institutions the patient is assisted throughout the stay by the attending physician. The hospital collaborates for all medical disciplines with the most famous physicians, who are requested according to the specificity of each case, all under the guidance of the AT-MED team. Excellent interdisciplinary collaboration among specialists is of crucial importance for the accuracy of diagnosis and the initiation of optimal therapy for each particular case. Based on the motto "Everything from a single source," the patient receives, with virtually no waiting time, all the medical services they need. Currently, AT-MED is the official partner for top medical clinics and hospitals in Austria: AK

OTHER WHITEPAPERS
news image

Strengthening Engagement and Influence with Key Decision Makers

whitePaper | January 5, 2023

This report follows up on the jointly hosted Pharmaforce and elandas webinar which took place on July, 12, 2016, featuring contributions from participating industry leaders who formed the expert panel, as well as the live contributions of the audience of healthcare sales and marketing professionals.

Read More
news image

Overcoming Pharma’s Launch Performance Problem

whitePaper | March 24, 2023

The prescription medicine market recovered from the wild swings of the early pandemic with renewed volume growth, driven by generics. COVID-19 vaccines and treatments have created a substantial market.

Read More
news image

Redefining the Role of Health Systems as a Specialty Pharmacy Solution for Drug Manufacturers

whitePaper | January 10, 2023

The ideal care model for complex patients is a model in which the entire health care team is made up of experts in the specific disease state being treated. Integrated health care systems and major academic medical centers provide this level of expertise and coordination.

Read More
news image

Starting Materials For Homeopathic Drug Products

whitePaper | December 31, 2021

The scope of this white paper includes GMPs relevant for mass manufacturing/batch53 processing of products intended for widescale retail marketing. Starting materials and 54 packaging components for drug products

Read More
news image

Three Challenges Facing Study Start Up and the Low-Code Solution

whitePaper | December 22, 2022

The life sciences industry has been exploring ways to accelerate the study start up process for well over a decade. The industry has long understood the value behind faster clinical trials: the sooner clinical trial results can be delivered to agencies, the sooner a new treatment can be available for patients.

Read More
news image

WILL PHARMA COMMIT TO DELIVERING AFFORDABLE THERAPEUTICS AGAINST COVID-19?

whitePaper | April 8, 2020

EPHA is a change agent – Europe’s leading NGO alliance advocating for better health. We are a dynamic member-led organisation, made up of public health civil society, patient groups, health professionals, and disease groups working together to improve health and strengthen the voice of public health in Europe.

Read More

Spotlight

Austriamed - Medical Treatments in Austria

AT-MED offers access to premium medical services in top clinics and hospitals in Austria. Through AT-MED you have full medical testings in half a day, in the same medical unit and a reliable team made up of world-renowned doctors and professors, for whom your needs will come first. In the Austrian medical institutions the patient is assisted throughout the stay by the attending physician. The hospital collaborates for all medical disciplines with the most famous physicians, who are requested according to the specificity of each case, all under the guidance of the AT-MED team. Excellent interdisciplinary collaboration among specialists is of crucial importance for the accuracy of diagnosis and the initiation of optimal therapy for each particular case. Based on the motto "Everything from a single source," the patient receives, with virtually no waiting time, all the medical services they need. Currently, AT-MED is the official partner for top medical clinics and hospitals in Austria: AK

Events